Effect of Irsal-e-Alaq (Leech Therapy) in Management of Niqris (Gout)
Not Applicable
- Conditions
- Health Condition 1: M109- Gout, unspecified
- Registration Number
- CTRI/2023/09/057624
- Lead Sponsor
- Aligarh Muslim University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosed cases of Gout
Patients willing to give informed written consent
Exclusion Criteria
Patients below the age of 25 and above the age of 65 years
Patients with uncontrolled Diabetes Mellitus & Hypertension
Pregnant and lactating patients
Patients with systemic disorders like Chronic Renal Failure & Coronary Artery Disease
Diagnosed cases of Osteoarthritis and Rheumatoid Arthritis
Patients having malignancy, psychological disorder
Patients taking Pyrazinamide
Immunocompromised patients
Patients of bleeding disorders, severe anaemia, hypotension.
Patients having allergy to leech
Patients who refuse to sign the consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VAS <br/ ><br>Serum uric acid levelTimepoint: Assessment on <br/ ><br>Baseline <br/ ><br>14th day <br/ ><br>28th day
- Secondary Outcome Measures
Name Time Method Gout Impact Scale <br/ ><br>Tenderness <br/ ><br>Stiffness <br/ ><br>Swelling <br/ ><br>Redness <br/ ><br>Temperature of affected joint <br/ ><br>Restriction of movementTimepoint: Assessment on <br/ ><br>Baseline <br/ ><br>14th day <br/ ><br>28th day